Clinical Trials Logo

Tobacco Use Cessation clinical trials

View clinical trials related to Tobacco Use Cessation.

Filter by:

NCT ID: NCT01915836 Completed - Clinical trials for Tobacco Use Cessation

Quit IT: Development of a Web-based, 3D Coping Skills Game to Increase Self-Efficacy for Maintaining Smoking Abstinence Following Hospitalization

Start date: March 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to test a web-based video game to help cancer patients quit smoking. The investigators are interested in what participants like and do not like about the game.

NCT ID: NCT01898195 Completed - Clinical trials for Tobacco Use Cessation

Improving Adherence to Smoking Cessation Medication Among PLWHA

HIV
Start date: March 2013
Phase: N/A
Study type: Interventional

Smoking rates among individuals living with HIV/AIDS range between 47% and 65%, a prevalence that is roughly three times the rate of the general population. This elevated prevalence is alarming given the increased likelihood of numerous adverse health outcomes experienced by HIV-positive smokers. Cigarette smoking is associated with greater levels of HIV-related symptom burden and appears to decrease the effectiveness of HAART as assessed by both viral load and CD4 counts (Vidrine 2009, Marshall 2009, Vidrine 2007, Miguez-Burbane 2005). PLWHA who smoke are also at increased risk of infections and noninfectious pulmonary complications and both AIDS-associated and non-AIDS-associated malignancies compared to nonsmokers. This study will refine and pilot test a theory-driven smoking cessation intervention that enhances existing behavioral approaches by testing the impact of text message reminders to take varenicline and the feasibility and additional impact of including adherence-focused behavioral cessation counseling. The investigators propose to randomize 190 participants, recruited from three HIV/AIDS clinic, to a three arm pilot study that compares: 1) Standard Care (SC), 2) SC + text message reminders, and 3) SC + text message reminders + cell phone-delivered adherence-focused behavioral therapy (ABT). Participants in all three arms will receive varenicline for 12 weeks. The primary outcomes are adherence to varenicline and biochemically validated smoking abstinence at 12 weeks and 3-month follow-up from the time of study enrollment.

NCT ID: NCT01885221 Completed - Clinical trials for Tobacco Use Cessation

A Multi-Media Approach to Partner Support in Smokeless Tobacco Cessation (UCare-ChewFree)

Start date: September 1, 2012
Phase: N/A
Study type: Interventional

In an earlier study, the investigators developed a guidebook that taught women supportive behaviors to help their husbands/partners quit smokeless tobacco. This study will create a website using the information in the guidebook, along with interactive features, videos, and forums. The investigators will then conduct a randomized trial comparing an intervention group (receiving website access and the printed guidebook) with a delayed treatment control condition, to learn if the support intervention can effectively teach women supportive behaviors and thereby increase their partners' smokeless tobacco cessation rates.

NCT ID: NCT01841879 Completed - Clinical trials for Tobacco Use Cessation

Mumbai Worksite Tobacco Control Study

Start date: June 2010
Phase: N/A
Study type: Interventional

The investigators are designing and testing the effectiveness of an integrated tobacco control and occupational health (OH) intervention aimed at promoting tobacco cessation among workers and supporting the adoption, implementation, and enforcement of tobacco control policies in 20 manufacturing worksites in the greater Mumbai region of India.

NCT ID: NCT01811628 Completed - Clinical trials for Tobacco Use Cessation

Project Impact: A Culturally-Tailored Adherence Intervention for Latino Smokers

Start date: July 17, 2013
Phase: N/A
Study type: Observational

The goal of this research study is to collect information from Latino and Hispanic smokers and recent quitters about factors that are important to them when they are trying to quit. Researchers want to better understand some of the challenges and problems that Latinos and Hispanics face when they try to quit smoking, and then use that information to design a treatment for future smokers.

NCT ID: NCT01798394 Active, not recruiting - Clinical trials for Tobacco Use Disorder

Progesterone & Postpartum Relapse to Smoking

Start date: June 2014
Phase: N/A
Study type: Interventional

The primary goal of this project is to investigate the potential efficacy of exogenous progesterone (with supplemental relapse prevention counseling) on postpartum relapse in new mothers. Also to determine the feasibility of enhanced compliance monitoring and identification of collateral factors effecting outcomes.

NCT ID: NCT01788787 Active, not recruiting - Clinical trials for Tobacco Use Cessation

Ask Advise Connect (AAC) Harris Heath CPRIT

Start date: April 2013
Phase:
Study type: Observational

The goal of this behavioral research study is to learn about the outcomes of smoking cessation treatment. Researchers want to learn how many smokers stopped smoking after taking part in smoking cessation treatment with the Texas Quitline.

NCT ID: NCT01722747 Completed - Clinical trials for Tobacco Use Cessation

Bihar School Teachers Study

BSTS
Start date: June 2009
Phase: N/A
Study type: Interventional

BRIEF SUMMARY: This study, which is closed to enrollment, is testing the efficacy of a tobacco-control intervention geared towards school teachers in Bihar, India. This cluster randomized trial aims to promote tobacco use cessation among teachers and increase tobacco policy adoption in 72 Bihar schools. Teachers are the focus of the study because as role models for youth and key opinion leaders related to community norms, they represent an important group for tobacco control. Teachers in Bihar also have reported high rates of tobacco use. According to the Global School Personnel Survey conducted in 2006, 39% of teachers in the eastern region of India (which includes Bihar) use some form of tobacco, compared to the national average of 29%. This study aims to reduce these numbers through discussion groups with teachers, individual cessation counseling, educational materials, and a tobacco policy workgroup in each intervention school. This study is a collaboration between US researchers and researchers at the Healis-Sekhsaria Institute for Public Health, Mumbai India.

NCT ID: NCT01699828 Completed - Smoking Cessation Clinical Trials

Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET

Start date: October 2012
Phase: Phase 1/Phase 2
Study type: Interventional

The objective of the present study is to use positron emission tomography brain imaging to investigate D3 occupancy of buspirone, an FDA-approved anxiolytic which acts as a serotonin partial agonist but has recently been identified as a D3 antagonist. It is hypothesized that clinically relevant doses of buspirone will occupy the D3 receptor.

NCT ID: NCT01691105 Completed - Smoking Cessation Clinical Trials

Implementation of HIT-Enhanced Tobacco Treatment for Hospitalized Smokers

Start date: August 2013
Phase: N/A
Study type: Interventional

This study will implement and test the effectiveness and cost-effectiveness of a tobacco cessation intervention (Academic Detailing + Integrated Tobacco Order Set - AD + ITOS) for adults admitted to the hospital. The intervention will begin during the hospital stay and continue after discharge. The intervention will use resources easily available to most acute care hospitals: computerized physician order entry, physician and nurse education, staff meetings for physicians, nurses and allied health professionals, online learning capabilities, faxing to primary care providers (PCPs), and the telephone counseling and support available from a state smokers' quitline (QL). The investigators hypothesize that the subjects in the intervention arm (AD + ITOS) will be more likely to achieve tobacco abstinence at 12 months post hospital stay than subjects in the control arm (Academic Detailing - AD). Tobacco abstinence will be assessed by self report and biochemical verification (exhaled carbon monoxide reading).